Back to Journals » Clinical Epidemiology » Volume 18

Incidence and Risk Factors of Postoperative Urinary Retention in Gynecologic Surgery: A Systematic Review and Meta-Analysis

Authors Hasanah A ORCID logo, Maryati I ORCID logo, Ermiati E ORCID logo

Received 3 February 2026

Accepted for publication 23 March 2026

Published 11 April 2026 Volume 2026:18 595297

DOI https://doi.org/10.2147/CLEP.S595297

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Erzsébet Horváth-Puhó



Postoperative Urinary Retention in Gynecologic Surgery – Video abstract [595297]

Views: 46

Anisa Hasanah,1 Ida Maryati,2 Ermiati Ermiati2

1Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 2Department of Maternity, Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia

Correspondence: Ida Maryati, Department of Maternity, Faculty of Nursing, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang KM 21, Hegarmanah, Jatinangor, Sumedang, West Java, 45363, Indonesia, Tel +628122109363, Fax +6222-7795596, Email [email protected]

Background: Postoperative urinary retention (POUR) is a frequent complication after gynecologic surgery, with wide variability in reported incidence due to differences in procedures and outcome definitions, and a lack of standardized quantitative synthesis.
Objective: To estimate the incidence of POUR following gynecologic surgery and summarize associated risk factors and preventive strategies.
Methods: A PRISMA-based systematic review and meta-analysis was conducted using PubMed, Scopus, EBSCO, and ScienceDirect. The review protocol was prospectively registered on the Open Science Framework (OSF; DOI: 10.17605/OSF.IO/W8CYR). Random-effects models were applied to estimate pooled incidence, with subgroup analyses by procedure and POUR definition. Associated factors were synthesized narratively.
Results: Thirty-four studies including 20,466 patients were analyzed. The pooled incidence of POUR was 16.1% (95% CI 12.8– 20.1; I2 = 97.3%). Incidence was highest after pelvic organ prolapse surgery (30.9%) and sling/mid-urethral sling procedures (25.3%), and lowest after minimally invasive benign hysterectomy (3.7%). Increased risk was associated with baseline voiding dysfunction, diabetes mellitus, vaginal surgical approach, and opioid exposure, while minimally invasive techniques and selected perioperative strategies were protective.
Conclusion: POUR is a common, procedure-dependent complication of gynecologic surgery. Procedure-specific risk stratification and standardized perioperative pathways are needed to reduce POUR and improve postoperative recovery.

Keywords: postoperative urinary retention, gynecologic surgery, incidence, risk factors, meta-analysis

Introduction

Postoperative urinary retention (POUR) is a clinically significant postoperative complication characterized by the inability to adequately empty the bladder despite sufficient bladder volume or distension.1 POUR remains a persistent concern across surgical disciplines, with reported incidence rates ranging from 5% to 70%, depending on the type of surgery, anesthetic modality, and diagnostic criteria applied.1,2 The International Continence Society (ICS) emphasizes the absence of a universally accepted definition for postoperative urinary retention, a limitation that has contributed to substantial heterogeneity in reported incidence rates and outcome assessment across studies.3

In gynecologic surgery, the risk of POUR is amplified due to the complexity of pelvic anatomy, the proximity of pelvic autonomic and somatic neural structures involved in micturition, and the wide variability in surgical techniques affecting urethral and bladder-supportive tissues. International evidence reports POUR incidence ranging from 2.5% to 43%, with the highest rates observed following pelvic organ prolapse (POP) reconstruction and mid-urethral sling (MUS) procedures.4,5 Evidence from Indonesia similarly demonstrates elevated incidence, reaching 29% among POP patients undergoing reconstructive surgery.6 Additionally, a prospective cohort study in Uganda reported a 19.6% incidence of POUR following perineal tear repair, highlighting that POUR is also clinically relevant in less complex gynecologic procedures.7

From a clinical perspective, POUR may result in sustained bladder overdistension, detrusor muscle injury, urinary tract infection, postoperative pain, delayed ambulation, prolonged catheterization, and increased length of hospital stay.1,4,8 A range of perioperative and patient-related risk factors has been consistently implicated, including advanced age, diabetes mellitus, low body mass index, prolonged operative duration, excessive intraoperative fluid administration, opioid exposure, preoperative voiding abnormalities, and vaginal surgical approach.1,2 Proposed pathophysiological mechanisms underlying POUR include periurethral tissue edema, local inflammatory responses, disruption of pelvic afferent and efferent neural pathways, and pharmacologic suppression of detrusor contractility associated with anesthesia and opioid analgesia.

Despite the growing volume of literature examining POUR incidence and its associated risk factors, existing studies exhibit marked methodological variability. Differences in POUR definitions, study design, surgical populations, and outcome reporting substantially limit direct comparison and synthesis of findings across studies. Moreover, to date, no comprehensive review has systematically integrated quantitative evidence across contemporary gynecologic surgical approaches—including vaginal, laparoscopic, robotic, prolapse repair, and sling procedures—while simultaneously evaluating both incidence and selected risk factors using meta-analytic methods.

Accordingly, a systematic review with meta-analysis is warranted to provide a consolidated and quantitative synthesis of available evidence on the incidence and risk factors of postoperative urinary retention following gynecologic surgery. Such an approach is essential to inform perioperative care strategies, support early identification of patients at increased risk, guide voiding protocols, and ultimately optimize postoperative outcomes.

Methods

Study Design and Reporting

This systematic review and meta-analysis was conducted in accordance with the PRISMA guidelines, using a predefined methodology established prior to study selection and data extraction to minimize reporting bias.

Outcomes

The primary outcome was the incidence of postoperative urinary retention (POUR) following gynecologic surgery. Secondary outcomes included patient-, surgical-, anesthetic-, and perioperative-related risk factors, as well as the effects of selected preventive interventions or voiding protocols.

Search Strategy

A comprehensive literature search was performed in PubMed, Scopus, EBSCO, and ScienceDirect using MeSH terms and free-text keywords related to POUR, risk factors, incidence, and gynecologic surgery. Reference lists of eligible studies were manually screened for additional relevant articles.

Eligibility Criteria

Eligible studies included original research involving adult women undergoing gynecologic surgery that reported POUR incidence, associated risk factors, or intervention outcomes with extractable quantitative data. Editorials, reviews, case reports, non-gynecologic studies, animal studies, and conference abstracts without sufficient data were excluded.

Study Selection and Data Extraction

Two reviewers independently screened studies, assessed full texts, and extracted data using a standardized form. Discrepancies were resolved by consensus or third-party adjudication. Extracted data included study characteristics, surgical type, POUR definition, incidence data, and reported effect estimates.

Quality Assessment

Methodological quality was independently assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Tools, with disagreements resolved by consensus.

Data Synthesis and Analysis

Random-effects meta-analyses were performed using Comprehensive Meta-Analysis (CMA) software (version 3) for outcomes reported by at least three studies with comparable definitions and data, including pooled POUR incidence. Heterogeneity was assessed using the I2 statistic, and subgroup analyses were conducted by surgical category and POUR definition when applicable. Potential publication bias was evaluated using visual inspection of funnel plots and Egger’s regression test when sufficient studies were available. Outcomes unsuitable for pooling were synthesized narratively using structured tables and thematic grouping.

Protocol Registration

The review protocol was not registered in PROSPERO. However, it was prospectively registered on the Open Science Framework (OSF) prior to data extraction and followed a predefined methodology in accordance with PRISMA recommendations (DOI: 10.17605/OSF.IO/W8CYR).

Results

Study Selection, Quality Assessment, and Study Characteristics

The literature search identified 1030 records, of which 940 unique articles were screened after duplicate removal. Following full-text assessment of 65 studies, 34 studies met the inclusion criteria and were included in the systematic review (Figure 1). Methodological quality, assessed using the Joanna Briggs Institute Critical Appraisal Tools, was overall acceptable.

Figure 1 PRISMA Flow Diagram for the literature review on the Incidence and Risk Factors of Postoperative Urinary Retention in Gynecologic Surgery.

The included 34 studies, published between 2003 and 2025, involved 20466 patients undergoing gynecologic surgery and were predominantly conducted in the United States, with additional studies from Europe and Asia. Most studies were observational, with a smaller number of randomized controlled trials evaluating perioperative interventions. Surgical procedures included benign hysterectomy, pelvic organ prolapse surgery, mid-urethral sling procedures, and gynecologic oncology surgery, with sample sizes ranging from 55 to 4743 patients. Reported POUR incidence ranged widely (0–86.2%), reflecting heterogeneity in procedures and outcome definitions (Table 1).

Table 1 Characteristics and Incidence of Postoperative Urinary Retention (POUR) in Included Studies (n=34)

Postoperative Urinary Retention Incidence

The pooled cumulative incidence of postoperative urinary retention following gynecologic surgery was 16.1% (95% CI 12.8–20.1), with substantial variability across surgical procedures and outcome definitions, reaching the highest incidence after pelvic organ prolapse surgery and when POUR was defined as failure of a voiding trial (Table 2). The forest plot illustrates marked between-study heterogeneity, with incidence estimates ranging from near zero to over 80%, supporting the use of a random-effects model (I2 = 97.3%) (Figure 2).

Table 2 Pooled Cumulative Incidence of Postoperative Urinary Retention (POUR) Following Gynecologic Surgery (n=34)

Figure 2 Forest plot of pooled cumulative incidence of postoperative urinary retention following gynecologic surgery.

Notes: Event rate indicates cumulative incidence of postoperative urinary retention; pooled estimates were derived using a random-effects model (τ2 = 0.569; I2 = 97.3%; Q = 1207.6, df = 33, p < 0.001).

Publication Bias

Funnel plot inspection suggested mild asymmetry (Figure 3), which was supported by a significant Egger’s regression test (p = 0.005). However, the classic fail-safe N indicated that 4206 missing studies would be required to nullify the pooled estimate, supporting the robustness of the findings.

Figure 3 Funnel plot for pooled incidence of POUR.

Notes: Funnel plot showed asymmetry; Egger’s test was significant (p = 0.005), with a large fail-safe N (4206).

Factors Associated with Postoperative Urinary Retention

Postoperative urinary retention was associated with patient, surgical, and perioperative factors, while several pharmacologic, minimally invasive, and voiding-related strategies were protective; due to substantial heterogeneity in definitions and effect measures, associated factors were synthesized narratively without quantitative meta-analysis (Table 3).

Table 3 Factors Associated with Postoperative Urinary Retention (POUR) Following Gynecologic Surgery (n=34)

Discussion

This systematic review and meta-analysis demonstrate that postoperative urinary retention (POUR) remains a frequent and clinically relevant complication following gynecologic surgery, with a pooled cumulative incidence of 16.1%, albeit with substantial variability across procedures and outcome definitions. The highest incidence was consistently observed following pelvic organ prolapse (POP) surgery and sling or mid-urethral sling (MUS) procedures, whereas ambulatory minimally invasive hysterectomy was associated with markedly lower rates. These findings corroborate prior evidence indicating that the degree of pelvic tissue manipulation and neural disruption—particularly in vaginal and reconstructive surgery—plays a central role in postoperative voiding dysfunction.5,35,40 Importantly, the elevated risk observed in these procedures may also reflect underlying baseline conditions, such as pelvic organ prolapse, which is a common indication for vaginal reconstructive surgery.11,13

Patient-related and functional factors were strongly implicated in POUR risk. Age demonstrated a context-dependent effect, with younger age increasing risk in outpatient POP surgery and older age associated with prolonged retention in MUS, radical endometriosis, and oncologic procedures.9,20,36 These divergent patterns likely reflect age-related differences in bladder compliance, detrusor reserve, and compensatory capacity. Diabetes mellitus emerged as a consistent predictor of POUR, supporting established evidence that diabetic autonomic neuropathy impairs parasympathetic regulation of detrusor contraction, resulting in reduced bladder sensation and increased post-void residual volumes.42,43 In line with this mechanism, abnormal preoperative voiding parameters—including elevated PVR, Valsalva voiding patterns, and low Qmax—were repeatedly associated with postoperative retention,29,31,40 consistent with International Continence Society guidance identifying patients with baseline voiding dysfunction as a high-risk population.3

Several perioperative factors appeared potentially modifiable. Perioperative opioid exposure demonstrated a consistent dose-dependent association with POUR, likely mediated by μ-opioid receptor–induced suppression of detrusor contractility and increased urethral sphincter tone.2,12 In contrast, anesthetic modality alone showed inconsistent associations, suggesting that surgical manipulation and postoperative analgesic strategies may exert greater influence on postoperative voiding than anesthesia type itself. Preventive strategies such as perioperative alpha-blockers, sugammadex use, early pelvic floor muscle training, and liberal or backfill-assisted voiding protocols were associated with reduced POUR incidence or facilitated discharge in selected populations,15,17,34,41 although their effectiveness appeared procedure-specific.

Assessment of reporting bias suggested the presence of possible small-study effects, as indicated by funnel plot asymmetry and a statistically significant Egger’s regression test. However, the large classic fail-safe N indicates that a substantial number of hypothetical unpublished studies would be required to negate the observed pooled incidence estimate. Taken together, these findings suggest that although publication bias or small-study effects cannot be entirely excluded, the overall conclusions regarding the incidence and procedural variability of POUR are robust and unlikely to be materially altered.

Collectively, these findings support a multifactorial conceptual model of POUR in which baseline bladder dysfunction, procedure-related pelvic and neural injury, and perioperative modifiers interact to overwhelm postoperative voiding capacity. Recognition of these interacting domains may facilitate more precise perioperative risk stratification and individualized management pathways.

Limitations

Marked heterogeneity in POUR definitions and assessment methods, along with predominantly observational study designs, limited comparability and precluded quantitative synthesis of associated risk factors. Additionally, evidence of small-study effects underscores the need for cautious interpretation of pooled estimates, particularly given the clinical and methodological diversity of included studies.

Conclusion

Postoperative urinary retention is a frequent, procedure-dependent complication of gynecologic surgery, with highest risk after vaginal and reconstructive procedures and lowest after minimally invasive hysterectomy, underscoring the importance of targeted risk stratification and standardized prevention strategies. Part of the observed risk in these procedures may also relate to underlying baseline pelvic floor conditions, such as pelvic organ prolapse, which are common indications for reconstructive surgery.

Data Sharing Statement

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

Acknowledgments

The author gratefully acknowledges Universitas Padjadjaran for providing access to research databases and financial support for this study.

Disclosure

The authors declare no conflicts of interest in this work.

References

1. Baldini G, Bagry H, Aprikian A, Carli F, Warner D, Warner M. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009;110(5):1139–10. doi:10.1097/ALN.0b013e31819f7aea

2. Keita H, Diouf E, Tubach F, et al. Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesth Analg. 2005;101(2):592–596. doi:10.1213/01.ANE.0000159165.90094.40

3. International Continence Society. Urinary retention. ICS Standardisation Terminology Discussion Group; 2018. Available from: https://www.ics.org/committees/standardisation/terminologydiscussions/urinaryretention. Accessed March 30, 2026.

4. Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Womens Health. 2014;6:829–838. doi:10.2147/IJWH.S55383

5. Ghezzi F, Cromi A, Uccella S, et al. Immediate Foley removal after laparoscopic and vaginal hysterectomy: determinants of postoperative urinary retention. J Minim Invasive Gynecol. 2007;14(6):706–711. doi:10.1016/j.jmig.2007.06.013

6. Triarani H, Priyatini T. Postoperative urinary retention in total vaginal and abdominal hysterectomy in benign gynecological disorders. Indones J Obstet Gynecol. 2015;3(1):44–50.

7. Kayondo M, Byamukama O, Ainomugisha B, et al. Incidence of and risk factors for postoperative urinary retention following surgery for perineal tears among Ugandan women: a prospective cohort study. Int Urogynecol J. 2024;35(8):1673–1679. doi:10.1007/s00192-024-05855-8

8. Pomajzl AJ, Siref LE. Postoperative urinary retention. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK549844/. Accessed March 30, 2026.

9. Alas A, Hidalgo R, Espaillat L, et al. Does spinal anesthesia lead to postoperative urinary retention in same-day urogynecology surgery? A retrospective review. Int Urogynecol J. 2019;30(8):1283–1289. doi:10.1007/s00192-019-03893-1

10. Alas A, Martin L, Devakumar H, et al. Anesthetics’ role in postoperative urinary retention after pelvic organ prolapse surgery with concomitant midurethral slings: a randomized clinical trial. Int Urogynecol J. 2019;30(8):1291–1299. doi:10.1007/s00192-019-03917-w

11. Anglim BC, Tomlinson G, Paquette J, McDermott CD. A risk calculator for postoperative urinary retention (POUR) following vaginal pelvic floor surgery: multivariable prediction modelling. BJOG. 2022;129(13):2203–2213. doi:10.1111/1471-0528.17225

12. Behbehani S, Delara R, Yi J, et al. Predictors of postoperative urinary retention in outpatient minimally invasive hysterectomy. J Minim Invasive Gynecol. 2020;27(3):681–686. doi:10.1016/j.jmig.2019.06.003

13. Bekos C, Morgenbesser R, Kölbl H, et al. Uterus preservation in vaginal prolapse surgery acts as a protector against postoperative urinary retention. J Clin Med. 2020;9(11):3773. doi:10.3390/jcm9113773

14. Bødkær B, Lose G. Postoperative urinary retention in gynecologic patients. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(2):94–97. doi:10.1007/s00192-003-1038-3

15. Chapman GC, Sheyn D, Slopnick EA, et al. Tamsulosin versus placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery. Am J Obstet Gynecol. 2021;225(3):274.e1–274.e11. doi:10.1016/j.ajog.2021.04.236

16. Chong W, Dabney L, Kiernan M, Oliva M, Ascher-Walsh C. Comparison of postoperative voiding dysfunction in two different voiding trials after tension-free vaginal tape. Am J Obstet Gynecol. 2018;218(2 Suppl):S906–S907. doi:10.1016/j.ajog.2017.12.040

17. de Lima Laporta Miranda ML, Kinney MAO, Bakkum-Gamez JN, et al. Sugammadex and urinary retention after hysterectomy: a propensity-matched cohort study. Biomol Biomed. 2024;24(2):395–400. doi:10.17305/bb.2023.9569

18. Delgado S, Wright KN, Jan A, Vogell AB. Incidence and risk factors for urinary retention in patients undergoing outpatient hysterectomy. J Gynecol Surg. 2021;37(3):252–256. doi:10.1089/gyn.2020.0178

19. Foster RT, Borawski KM, South MM, et al. A randomized controlled trial evaluating two techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol. 2007;197(6):627.e1–627.e4. doi:10.1016/j.ajog.2007.08.017

20. Gabriel B, Nassif J, Trompoukis P, et al. Prevalence and outcome of urinary retention after laparoscopic surgery for severe endometriosis. Int Urogynecol J. 2012;23(1):111–116. doi:10.1007/s00192-011-1492-2

21. Hwang WY, Kim K, Cho HY, et al. The voiding VAS score for predicting postoperative urinary retention after laparoscopy. J Obstet Gynaecol. 2022;42(6):2469–2473. doi:10.1080/01443615.2022.2071149

22. Ishino A, Tucker LY, Navarrete E, et al. Active versus passive voiding protocols after same-day minimally invasive hysterectomy. J Minim Invasive Gynecol. 2022;29(1):144–150. doi:10.1016/j.jmig.2021.07.016

23. Le Neveu M, Davis J, Patzkowsky K, Frost A. Reevaluating the requirement to void following minimally invasive hysterectomy. Am J Obstet Gynecol. 2025;232:390–396. doi:10.1016/j.ajog.2025.03.038

24. Leffelman A, Chill H, Paya-Ten C, et al. Effect of preoperative tamsulosin on postoperative urinary retention after sling placement. Int Urogynecol J. 2025;36(5):1085–1093. doi:10.1007/s00192-025-06120-2

25. Loo ZX, Chen HS, Tang FH, et al. Predictors of voiding dysfunction following Uphold™ mesh repair. Eur J Obstet Gynecol Reprod Biol. 2020;255:34–39. doi:10.1016/j.ejogrb.2020.09.041

26. McLarty KB, Zuo SW, Warner KJ, et al. Effect of older age on postoperative urinary retention after prolapse surgery. Urogynecology. 2025;31(4):390–396. doi:10.1097/SPV.0000000000001631

27. Morey AF, Medendorp AR, Noller MW, et al. Transobturator versus transabdominal midurethral slings. J Urol. 2006;175(3):1014–1017. doi:10.1016/S0022-5347(05)00412-X

28. Nguyen K, McCormack L, Deans R, et al. Bladder function following endometriosis surgery with long-term follow-up. J Minim Invasive Gynecol. 2024;31(3):205–212. doi:10.1016/j.jmig.2023.11.020

29. Pham KN, Topp N, Guralnick ML, et al. Preoperative Valsalva voiding increases risk of urinary retention after midurethral sling placement. Int Urogynecol J. 2010;21(10):1243–1246. doi:10.1007/s00192-010-1177-2

30. Ripperda CM, Kowalski JT, Chaudhry ZQ, et al. Predictors of early postoperative voiding dysfunction. Am J Obstet Gynecol. 2016;215(5):656.e1–656.e6. doi:10.1016/j.ajog.2016.06.010

31. Salin A, Conquy S, Elie C, et al. Risk factors for voiding dysfunction following TVT placement. Eur Urol. 2007;51(3):782–787. doi:10.1016/j.eururo.2006.10.056

32. Samimi P, Siedhoff M, Greene N, Wright K. Patient discharge without an order to void. J Minim Invasive Gynecol. 2020;27(5):1059–1062. doi:10.1016/j.jmig.2019.09.770

33. Shah A, Molina A, Moeckel C, et al. Effect of voiding policy on PACU length of stay. J Minim Invasive Gynecol. 2025;32(5):432–437. doi:10.1016/j.jmig.2024.12.003

34. Siedhoff MT, Wright KN, Misal MA, et al. Postoperative urinary retention after benign gynecologic surgery. J Minim Invasive Gynecol. 2021;28(2):351–357. doi:10.1016/j.jmig.2020.07.002

35. Steinberg BJ, Finamore PS, Sastry DN, et al. Urinary retention after vaginal mesh procedures. Int Urogynecol J. 2010;21(12):1491–1498. doi:10.1007/s00192-010-1212-3

36. Sun MJ, Sun R, Chang YJ, et al. Risk factors of urinary retention after midurethral sling placement. Taiwan J Obstet Gynecol. 2025;64(2):287–292. doi:10.1016/j.tjog.2024.12.007

37. Wagar MK, Patel UJ, Bharucha K, et al. Postoperative urinary retention after radical hysterectomy. Gynecol Oncol. 2024;190:90–95. doi:10.1016/j.ygyno.2024.08.005

38. Wong KS, Mei JY, Wieslander CK, Tarnay CM. Anterior vaginal and apical position and postvoid residual. Female Pelvic Med Reconstr Surg. 2017;23(5):314–319. doi:10.1097/SPV.0000000000000390

39. Yu L, Chen X, Liu X. Factors influencing postoperative urinary retention in uterus-preserving surgery. Asian J Surg. 2025;48(8):4056–4057. doi:10.1016/j.asjsur.2025.01.096

40. Zhang BY, Wong JMH, Koenig NA, et al. Risk factors for urinary retention after urogynecologic surgery. Neurourol Urodyn. 2021;40(5):1–10. doi:10.1002/nau.24676

41. Zhang J, Zhang Y, Liu J, et al. Early pelvic floor muscle exercise after radical hysterectomy. Arch Esp Urol. 2025;78(5):579–587. doi:10.56434/j.arch.esp.urol.20257805.78

42. Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction. J Urol. 2009;182(6 Suppl):S18–S26. doi:10.1016/j.juro.2009.08.070

43. Golbidi S, Laher I. Bladder dysfunction in diabetes mellitus. Front Pharmacol. 2010;1:136. doi:10.3389/fphar.2010.00136

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.